Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage
Clinical trial NCT00589290 · COMPLETED
Trial details
- NCT number
- NCT00589290
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2013-07-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.